Search Results - "JAYAPRAKASH, Vijayvel"

Nivolumab treatment beyond RECIST‐defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial by Haddad, Robert, Concha‐Benavente, Fernando, Blumenschein, George, Fayette, Jerome, Guigay, Joel, Colevas, A. Dimitrios, Licitra, Lisa, Kasper, Stefan, Vokes, Everett E., Worden, Francis, Saba, Nabil F., Tahara, Makoto, Jayaprakash, Vijayvel, Lynch, Mark, Li, Li, Gillison, Maura L., Harrington, Kevin J., Ferris, Robert L.

“…Background Response patterns with immune checkpoint inhibitors may be different from those with chemotherapy. Therefore, assessment of response to…”
Get full text

Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database by Jayaprakash, Vijayvel, Merzianu, Mihai, Warren, Graham W., Arshad, Hassan, Hicks Jr, Wesley L., Rigual, Nestor R., Sullivan, Maureen A., Seshadri, Mukund, Marshall, James R., Cohan, David M., Zhao, Yujie, Singh, Anurag K.

“…Background The survival rates and prognostic factors for salivary duct carcinoma (SDC) are not clear. Methods Survival estimates and prognostic factors were…”
Get full text

Two‐year follow‐up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141) by Yen, Chia‐Jui, Kiyota, Naomi, Hanai, Nobuhiro, Takahashi, Shunji, Yokota, Tomoya, Iwae, Shigemichi, Shimizu, Yasushi, Hong, Ruey‐Long, Goto, Masahiro, Kang, Jin‐Hyoung, Li, Wing Sum Kenneth, Ferris, Robert L., Gillison, Maura, Endo, Toshimitsu, Jayaprakash, Vijayvel, Tahara, Makoto

“…Background The present study evaluated the 2‐year survival of the Asian population in the CheckMate 141 trial. Methods The CheckMate 141 trial included…”
Get full text

A Randomized Double-Blind Placebo-Controlled Phase IIB Trial of Curcumin in Oral Leukoplakia by Kuriakose, Moni Abraham, Ramdas, Kunnambath, Dey, Bindu, Iyer, Subramanya, Rajan, Gunaseelan, Elango, Kalavathy K, Suresh, Amritha, Ravindran, Divya, Kumar, Rajneesh R, R, Prathiba, Ramachandran, Surya, Kumar, Nisha Asok, Thomas, Gigi, Somanathan, Thara, Ravindran, Hiran K, Ranganathan, Kannan, Katakam, Sudhakar Babu, Parashuram, Shivashankar, Jayaprakash, Vijayvel, Pillai, M Radhakrishna

“…Oral leukoplakia is a potentially malignant lesion of the oral cavity, for which no effective treatment is available. We investigated the effectiveness of…”
Get full text

Folate intake and the risk of oral cavity and pharyngeal cancer: A pooled analysis within the International Head and Neck Cancer Epidemiology Consortium by Galeone, Carlotta, Edefonti, Valeria, Parpinel, Maria, Leoncini, Emanuele, Matsuo, Keitaro, Talamini, Renato, Olshan, Andrew F., Zevallos, Jose P., Winn, Deborah M., Jayaprakash, Vijayvel, Moysich, Kirsten, Zhang, Zuo‐Feng, Morgenstern, Hal, Levi, Fabio, Bosetti, Cristina, Kelsey, Karl, McClean, Michael, Schantz, Stimson, Yu, Guo‐Pei, Boffetta, Paolo, Lee, Yuan‐Chin Amy, Hashibe, Mia, Vecchia, Carlo, Boccia, Stefania

“…There are suggestions of an inverse association between folate intake and serum folate levels and the risk of oral cavity and pharyngeal cancers (OPCs), but…”
Get full text

Enterococcus faecalis Enhances Cell Proliferation through Hydrogen Peroxide-Mediated Epidermal Growth Factor Receptor Activation by BOONANANTANASARN, Kanitsak, LINDLEY GILL, Ann, YAP, Yoonsing, JAYAPRAKASH, Vijayvel, SULLIVAN, Maureen A, GILL, Steven R

“…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Selenium and other antioxidants for chemoprevention of gastrointestinal cancers by Jayaprakash, Vijayvel, MBBS, PhD, Marshall, James R., BA, MA, PhD

“…Antioxidants such as selenium, vitamin E and C and carotenoids have been hypothesized as chemopreventive agents for several cancers. In the current review, we…”
Get full text

Osteonecrosis of the jaw – Prevention and treatment strategies for oral health professionals by Hinchy, Nicole V, Jayaprakash, Vijayvel, Rossitto, Rachael A, Anders, Patrick L, Korff, Kathryn C, Canallatos, Paul, Sullivan, Maureen A

“…Summary Patients diagnosed with multiple myeloma and metastatic breast, prostate and renal cancers have a better opportunity for longer survival due to a…”
Get full text

Cruciferous vegetable intake is inversely associated with lung cancer risk among smokers: a case-control study by Tang, Li, Zirpoli, Gary R, Jayaprakash, Vijayvel, Reid, Mary E, McCann, Susan E, Nwogu, Chukwumere E, Zhang, Yuesheng, Ambrosone, Christine B, Moysich, Kirsten B

“…Inverse associations between cruciferous vegetable intake and lung cancer risk have been consistently reported. However, associations within smoking status…”
Get full text

Previous Head and Neck Cancers Portend Poor Prognoses in Lung Cancer Patients by Jayaprakash, Vijayvel, MBBS, PhD, Cheng, Cheng, BS, Reid, Mary, PhD, Dexter, Elisabeth U., MD, Nwogu, Chukwumere E., MD, Hicks, Wesley, MD, Sullivan, Maureen, DDS, Demmy, Todd L., MD, Yendamuri, Sai, MBBS

“…Background Although a common clinical pairing, the epidemiology and prognosis of lung cancer (LC) after head and neck cancer (HNC) is not well described…”
Get full text

Regular aspirin use and esophageal cancer risk by Jayaprakash, Vijayvel, Menezes, Ravi J., Javle, Milind M., McCann, Susan E., Baker, Julie A., Reid, Mary E., Natarajan, Nachimuthu, Moysich, Kirsten B.

“…Given the high mortality rate and the rapidly increasing incidence rate of esophageal carcinoma, chemopreventive agents are highly desirable. Aspirin has been…”
Get full text

Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression by Ferris, Robert L., Blumenschein, George, Fayette, Jerome, Guigay, Joel, Colevas, A. Dimitrios, Licitra, Lisa, Harrington, Kevin J., Kasper, Stefan, Vokes, Everett E., Even, Caroline, Worden, Francis, Saba, Nabil F., Docampo, Lara Carmen Iglesias, Haddad, Robert, Rordorf, Tamara, Kiyota, Naomi, Tahara, Makoto, Lynch, Mark, Jayaprakash, Vijayvel, Li, Li, Gillison, Maura L.

“…•Nivolumab showed prolonged OS benefit in patients with R/M SCCHN post-platinum.•Long-term OS benefit was observed irrespective of PD-L1 expression or HPV…”
Get full text

A Phase 1, Open-Label, Multicenter Study of HMPL-306 in Advanced Hematological Malignancies with Isocitrate Dehydrogenase (IDH) Mutations by Doraiswamy, Anu, Jayaprakash, Vijayvel, Kania, Marek, Hahka-Kemppinen, Marjo, Yang, Zhao, Rudinski, Mark, Ravandi, Farhad

“…Background: Isocitrate dehydrogenase (IDH) is a rate-limiting tricarboxylic acid cycle enzyme with 3 isoforms. Mutations in IDH1 and IDH2 result in…”
Get full text

An Analysis of Current Techniques Used for Intraoperative Flap Evaluation by Lohman, Robert F, Ozturk, Cemile Nurdan, Ozturk, Can, Jayaprakash, Vijayvel, Djohan, Risal

“…BACKGROUNDOver the last decade, microsurgeons have used a greater variety of more complex flaps. At the same time, microsurgeons have also become more…”
Get full text

Preliminary Results from a Phase I Study of HMPL-523, a Selective Oral Syk Inhibitor, in Patients with Relapsed or Refractory Lymphoma by Strati, Paolo, Chraniuk, Dominik, González-Barca, Eva, Taszner, Michal, Pillai, Rathi, Chien, Caly, Nanda, Shivani, Rudinski, Mark, Jayaprakash, Vijayvel, Hahka-Kemppinen, Marjo, Kania, Marek

“…Background: Spleen tyrosine kinase (Syk) plays an integral role in B-cell receptor signaling critical in the development and survival of several subtypes of…”
Get full text

Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141 by Gillison, Maura L, Blumenschein, George, Fayette, Jerome, Guigay, Joel, Colevas, A Dimitrios, Licitra, Lisa, Harrington, Kevin J, Kasper, Stefan, Vokes, Everett E, Even, Caroline, Worden, Francis, Saba, Nabil F, Iglesias Docampo, Lara Carmen, Haddad, Robert, Rordorf, Tamara, Kiyota, Naomi, Tahara, Makoto, Jayaprakash, Vijayvel, Wei, Li, Ferris, Robert L

“…In the randomized, phase 3 CheckMate 141 trial, nivolumab significantly improved overall survival (OS) versus investigator's choice (IC) of chemotherapy at…”
Get full text

Nivolumab versus investigator’s choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by age by Saba, Nabil F., Blumenschein, George, Guigay, Joel, Licitra, Lisa, Fayette, Jerome, Harrington, Kevin J., Kiyota, Naomi, Gillison, Maura L., Ferris, Robert L., Jayaprakash, Vijayvel, Li, Li, Brossart, Peter

“…•CheckMate 141 evaluated nivolumab in patients with R/M SCCHN post-platinum therapy.•We present a post hoc analysis of CheckMate 141 evaluating patient…”
Get full text

Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: A meta-analysis, 1985–2010 by Jayaprakash, Vijayvel, Reid, Mary, Hatton, Elizabeth, Merzianu, Mihai, Rigual, Nestor, Marshall, James, Gill, Steve, Frustino, Jennifer, Wilding, Gregory, Loree, Thom, Popat, Saurin, Sullivan, Maureen

“…Summary Human papillomavirus (HPV) types 16 and 18 are causally related to a sub-set of oral cavity and oropharyngeal squamous cell cancers. However, a clear…”
Get full text

ECHO-310: A phase 3, randomized trial of epacadostat + nivolumab + chemo vs EXTREME as first-line treatment of recurrent/metastatic SCCHN by Cohen, Ezra E.W., Mehra, Ranee, Psyrri, Amanda, Bauman, Julie E., Schaub, Richard, Zhou, Li, Li, Li, Jayaprakash, Vijayvel, Guigay, Joel

“…Abstract only…”
Get full text

Evolving techniques for negative pressure wound therapy and the value of grass roots comparative effectiveness research by Lohman, Robert, Jayaprakash, Vijayvel, Dorafshar, Amir, Gottlieb, Lawrence, Franczyk, Mieczyslawa

“…Abstract only 160 Background: There is debate over the value of comparative effectiveness research to address national health problems, but less attention has…”
Get full text